A global RNase MRP substrate hunt has never been performed. Results: We identified new potential substrates for RNase MRP. Conclusion: Results confirm a role for RNase MRP in the cell cycle and identify new roles in the biosynthesis of other RNA-protein complexes. Significance: Knowing the identity of RNase MRP substrates is critical to understanding its function and role on a system-wide scale.
RNase mitochondrial RNA processing (MRP) is an essential, evolutionarily conserved endoribonuclease composed of 10 different protein subunits and a single RNA. RNase MRP has established roles in multiple pathways including ribosome biogenesis, cell cycle regulation, and mitochondrial DNA replication. Although each of these functions is important to cell growth, additional functions may exist given the essential nature of the complex. To identify novel RNase MRP substrates, we utilized RNA immunoprecipitation and microarray chip analysis to identify RNA that physically associates with RNase MRP. We identified several new potential substrates for RNase MRP including a cell cycle-regulated transcript, CTS1; the yeast homolog of the mammalian p27 Kip1 , SIC1; and the U2 RNA component of the spliceosome. In addition, we found RNase MRP to be involved in the regulation of the Ty1 transposon RNA. These results reinforce and broaden the role of RNase MRP in cell cycle regulation and help to identify new roles of this endoribonuclease.
RNase mitochondrial RNA processing (MRP)
2 is a highly conserved and essential endoribonuclease enzyme complex present in all eukaryotes with known functions in mitochondrial DNA replication, ribosomal biosynthesis, and cell cycle regulation. The yeast RNase MRP is composed of 10 protein subunits and a 340-nucleotide RNA encoded by the NME1 gene, all of which are essential for viability. It shares eight of these proteins (Pop1p, Pop3p, Pop4p, Pop5p, Pop6p, Pop7p, Pop8p, and Rpp1) with the evolutionarily related RNase P, an endoribonuclease responsible for cleaving tRNA at its 5Ј-end as a normal part of the tRNA maturation process (1) (2) (3) (4) .
RNase MRP is found predominately localized to the nucleolus where it processes preribosomal RNA at the A3 site, leading to formation of the more abundant 5.8 S short ribosomal RNA (5, 6). RNase MRP is also present in the cytoplasm where it participates in cell cycle regulation (7-9) and within the mitochondria where it is proposed to be required for transcription-dependent mitochondrial DNA replication by cleaving a mitochondrial transcript RNA to form the replication primer (10, 11).
RNase MRP mutants exhibit a mitotic cell cycle delay characterized by the formation of large budded cells, an hourglassshaped nucleus that is split between mother and daughter cells, and a long mitotic spindle (7). The increased spindle stability in these mutants is caused by elevated levels of the B-type mitotic cyclin Clb2p, resulting in the extended activity of the Clb2p/ Cdc28p cyclin kinase pair and consequently an extended mitosis (9). In vitro and in vivo analyses showed that RNase MRP directly cleaves the 5Ј-untranslated region (UTR) of CLB2 mRNA in a site-specific manner, facilitating its rapid degradation by the 5Ј to 3Ј exoribonuclease Xrn1p (9). Human cells with a mutation in the gene encoding the human RNase MRP RNA (RMRP) have been shown to display a similar molecular defect in cyclin mRNA processing and rRNA processing (12, 13).
In yeast, RNase MRP colocalizes with Xrn1p in the cytoplasm of the daughter cell during mid-to-late mitosis in a pattern characterized by small punctate foci (temporal asymmetric MRP (TAM) bodies) that appear during anaphase. They are transported in a Myo4p-dependent manner to the cytoplasm of the daughter cell where they persist until cytokinesis (8). The localization of these foci is conditional on RNase MRP function, and they are proposed to be the sites of mRNA processing by RNase MRP and subsequent degradation by Xrn1 (8).
To determine whether RNase MRP has additional RNA substrates, we utilized TAP-tagged RNase MRP protein Rmp1 to affinity capture RNase MRP and its substrates. As the endori-bonuclease activity of the enzyme requires the physical association of the substrate with the enzyme, captured RNAs outside of the MRP RNA are expected to be candidate substrates. We identified the captured RNAs using oligonucleotide microarrays for Saccharomyces cerevisiae. We have modified this approach by subjecting the cells to ultraviolet light prior to lysis to covalently bind substrate RNA to the RNase MRP complex and thus increase the RNA substrate yield (14, 15). We have called this procedure RNA immunoprecipitation and microarray chip analysis (RIP-chip) (15). This methodology enabled us to identify several new RNase MRP substrates including CTS1, SIC1, LSR1 and to identify a role for RNase MRP in the Ty1 retrotransposon cycle.
EXPERIMENTAL PROCEDURES
Analysis of Yeast RNA-Extraction of RNA was performed as described previously (16). Separation and analysis of total RNA were performed as described (17) for both urea denaturing polyacrylamide and formaldehyde denaturing agarose gels. Northern blot analysis was performed as described (5). All DNA probes used were made by polymerase chain reaction (PCR) using the following primers: CTS1-F1 (AAA AAC CTC AGC AGC CTC AA), CTS1-R1 (GAA CTT CCC ATC AGC AGA GC), SIC1-F1 (GCC CTA ATG CAA GGT CAA AA), SIC-R1 (GAC TCC TGG CGT CAT TTT C), LSR1-F (CGG  CCA AAG TTG TTG ATT TT), LSR1-R (GCA TTC TTC AAA  TCC CTC CA), 5Ј-TERCTY1-2 (AAT GCA ATC TGA TAC  CCA AGA GGC), 3Ј-TERCTY1-2 (GAT AGG TGC AAG TAC  AGT GCC GTC), VPH1F1 (ATA TTT GGA CGG CTC AGG  TG), VPH1-R1 (TGT GGG TAA A CCA GCA TTG A), SCR1-F  (TGA TCA ACT TAG CCA GGA C), SCR1-R (GAT CAA CTT  GCA CAA TTA T), CTS1-F3 (GCG GCC GCC AAT TTA  GGT GAC ACT ATA GGA ATG GAC AAC AAC AAT ACA  TTA C) , and CTS1-R3 (GGA TCC GAA GAA TGA TGT AAA GGA GTG ACA. Probes were radiolabeled with [ 32 P]dCTP using the Prime-It II kit (Stratagene, Inc., La Jolla, CA) and purified by gel exclusion chromatography using G-50 Sephadex as described (17). Radioactive blots were analyzed on a GE Healthcare/Amersham Biosciences Typhoon variable mode imager. For Northern analysis, yeast strains were all grown at 28°C to late log phase and moved to 37°C for 2 h prior to harvesting cells for RNA.
In Vitro Cleavage Assay-The RNase MRP cleavage assays and the generation of 3Ј-end-labeled substrates were performed as described previously (9) using the pJA110 template for the A3 cleavage as a positive control. The template for the CTS1 substrate was generated by PCR amplification of the 5Ј-UTR of the CTS1 gene with a 5Ј primer bearing an SP6 polymerase promoter (CTS1-F3) and a 3Ј primer bearing a BamHI site (CTS1-R3). This fragment was cloned into the pRS315 vector and digested with BamHI for the synthesis of RNA with SP6 RNA polymerase. The substrate RNA is ϳ265 nucleotides.
Purification of RNase MRP-RNase MRP was purified from S. cerevisiae with the tandem affinity purification (TAP) tag protocol as described (1) . The Rmp1 TAP-tagged strain used in this manuscript is KLS116 (1) .
Primer Extension-Primer extension was carried out as described previously (9) with CTS1-R3 oligonucleotide labeled with [ 32 P]ATP and polynucleotide kinase on its 5Ј-end. The same primer was used in a DNA sequencing reaction and run in parallel on a sequencing gel as described (9).
Cell Synchronization and RNA Analysis-Erlenmeyer flasks containing 350 ml of synthetic complete dextrose (9) medium were each inoculated with isogenic strains carrying either the nme1-⌬2 allele or the wild-type NME1 allele to a density of 2.0 ϫ 10 6 cells/ml. The cultures were incubated at 28°C and shaken until the densities reached 1.5 ϫ 10 7 cells/ml. At that time, 25 ml of 210 mg/ml hydroxyurea (Arco; 99% pure) was added into each culture and incubated an additional 3 h whereupon cells were collected at 5000 rpm for 5 min at 28°C and washed four times with 35 ml of 28°C synthetic complete dextrose each time. Cells were suspended in 35 ml of 28°C synthetic complete dextrose, inoculated into 350 ml of synthetic complete dextrose, and incubated at 31°C. From these cultures, we collected 25 ml of cells at 15-min intervals from 0 to 180 min. Cell density was determined every 30 min using a hemocytometer. For each time point, cells were photographed from the most representative field for each culture at each time fraction using 450ϫ magnification with the differential interference contrast setting. After collection at each time point, cells were immediately stored at Ϫ80°C.
UV Cross-linking and Affinity Purification of RNase MRP Complex with Substrate-Erlenmeyer flasks containing 500 ml of yeast extract/peptone/dextrose medium were inoculated at 2.5 ϫ 10 6 cells/ml and incubated with shaking at 28°C for 8 h until they reached a density of around 5.0 ϫ 10 7 cells/ml. We performed UV irradiation by quickly transferring all of each culture to 12 ϫ 22-inch glass trays and irradiating cells for two 2-min intervals at 254 nm in a Stratagene Corp. Stratalinker (ϳ930 mJ/cm 2 ). Cultures were stirred between irradiations and collected at 5000 ϫ g for 5 min at 4°C. Cells were then washed in chilled water twice, collected as before, and stored at Ϫ80°C until lysis. Purification of RNase MRP with substrate was carried out as described previously (1) except that the calmodulin affinity column was not used. Instead, the tobacco etch virus protease elution was directly extracted as described below.
Proteinase K Treatment and Phenol/Chloroform Extraction-To the tobacco etch virus protease elution we added 20% SDS to a final concentration of 5% (v/v) and 2-mercaptoethanol to 10% (v/v) and then heated the sample to 95°C for 10 min. We allowed the samples to cool to room temperature, CaCl 2 was added to a final concentration of 5 mM, and Proteinase K was added to final a concentration of 100 g/ml. The sample was incubated at 50°C for 1 h followed by 95°C for 5 min to inactivate the Proteinase K. Phenol/chloroform extraction and ethanol precipitation of RNA were then performed as described (18). RNA pellets were suspended with 200 l of diethyl pyrocarbonate-treated double distilled H 2 O. RNA concentration and quality were determined by UV spectrophotometric analysis at 260 and 280 nm. Samples were run through an Agilent bioanalyzer on an RNA nanochip for qualitative analysis.
Microarray Analysis-Microarray analysis was performed in the State University of New York Upstate Medical University Microarray Core Facility using Affymetrix Yeast Genome S98 arrays. For RNA labeling, 100 ng of total RNA was amplified using Ovation RNA Amplification System V2 from NuGEN Technologies. The cDNA generated from this protocol was fragmented and biotin-labeled using the Encore Biotin Module. Each labeled cDNA sample was then hybridized to a microarray with incubation at 45°C in Affymetrix Hybridization Oven 645. After 18 h of incubation, the arrays were processed in Affymetrix Fluidics Station 450 using reagents from Affymetrix and standard protocols. Arrays were scanned with Affymetrix GeneChip Scanner 7G Plus.
RESULTS
To identify novel RNase MRP substrates, we utilized a previously characterized strain expressing an Rmp1 TAP-tagged allele, KLS116 (1). Yeast cells were cross-linked with UV irradiation as described under "Experimental Procedures," the RNase MRP enzyme was immunoprecipitated using the TAP tag, and co-purifying RNAs were isolated and hybridized to a DNA microarray. The data were parsed in two different ways: by a call on whether it was present or absent and by an overall change in signal level over an untagged control strain. A probe proximal to a well characterized RNase MRP cleavage site in the rRNA precursor was found to be overrepresented 17.38-fold over control. Hence, we made this the cutoff for a significant hit. Remaining were 70 positive probes that were found to be overrepresented from 17.7-to 210-fold over control. These represented 64 unique ORFs (Table 1 Many of these co-precipitating RNAs were encoded by ribosomal protein genes, but there were several groups of RNAs identified whose products are involved in other aspects of protein synthesis. However, most abundant in terms of hybridization signal were ribosomal protein transcripts. This abundance may be an artifact of their high abundance in a cell; however, levels of these transcripts were considerably lower or absent in the untagged strain. In addition to transcripts whose product is involved in translation, we encountered a small group of cell cycle-regulated transcripts.
Validation of Individual RNAs from the RIP-chip Data Set-To verify whether or not the individual RNAs identified by microarray analysis were indeed RNase MRP substrates, we first determined whether the steady-state level of each RNA was altered in RNase MRP mutants. Compared with wild-type cells, RNase MRP mutants exhibit decreased RNA processing ability, resulting in an increase in the stability and hence the amount of substrate RNA in the cell. This relative increase of substrate RNA in RNase MRP mutants compared with wildtype cells can be measured most effectively by Northern blot analysis. We selected several RNAs with elevated signals from the RIP-chip analysis: RPL31b, RPL34a, STM1, and LSR1 were chosen based on their exceptionally high hybridization levels; CTS1, SIC1, and HTB1 were selected as representative cell cycle-regulated transcripts; NOP1 was selected as representative of rRNA processing; and Ty1 RNA was examined because of the multiple hits we received with it. We choose four different RNase MRP mutant strains to examine RNA levels. Two of the mutants contained different temperature-sensitive alleles of the RNase MRP RNA, nme1-P6 and nme1-⌬2 (19), and two contained different temperature-sensitive alleles of a unique RNase MRP protein component, snm1-172 and snm1-P18 (18).
Total RNA was collected from all four yeast strains along with wild-type controls. RNA was separated, blotted, and probed using DNA probes specific for each mRNA. The steadystate mRNA levels of RPL31b, RPL34a, HTB1, NOP1, and STM1 showed only modest changes in the mutant strains as compared with the wild-type strains (data not shown). These results indicate that although these transcripts may associate with RNase MRP they are not necessarily substrates of the enzyme. In contrast, Northern blot analysis of SIC1, LSR1, and CTS1 indicated an increase in RNA levels consistent with RNase MRP playing a role in their degradation (Fig. 1) .
SIC1 mRNA Is Elevated in RNase MRP Mutants-SIC1, the yeast homolog of the p27
Kip1 cyclin-dependent kinase inhibitor, is a key regulator of mitotic exit and Clb2p abundance. Human p27 has been implicated in cell cycle deregulation and cancer development (20). SIC1 is expressed in a manner similar to but slightly later than CLB2 mRNA and is enriched Ͼ2-fold in RNase MRP mutants as determined by Northern blot analysis (Fig. 1A) . Furthermore, a sic1⌬/nme1-p6 double mutant exhibits a synthetic growth defect, indicating a genetic interaction likely due to their roles in reducing Clb2 activity ( Fig. 2A) . The elevated SIC1 mRNA levels and its association with Rmp1 strongly suggest that it is an RNase MRP substrate and indicate that RNase MRP may have additional roles in fine tuning mitotic exit.
LSR1 Levels Are Increased in RNase MRP Mutants-LSR1, the U2 snRNA and integral component of the spliceosome required for splicing of intron-bearing transcripts, exhibited a significant enrichment in the RIP-chip analysis. Northern analysis showed an elevation of LSR1 RNA levels in MRP mutants as compared with wild-type cells, indicating that RNase MRP may function in the assembly or degradation of this RNA (Fig. 1C) . We directly tested for genetic interactions between the nme1-P6 mutation and two non-essential protein components of the U2 small nuclear ribonucleoprotein, Msl1 and Lea1. Msl1 and Lea1 are the U2B component and U2A component of the U2 small nuclear ribonucleoprotein, respectively (21). Double mutants containing either msl1⌬/nme1-p6 or lea1⌬/nme1-p6 were found to be slow growing (Fig. 2B) . We also found that deletion of DBR1, the gene for the debranching enzyme that resolves the excised intron lariat (22) , is growth-defective in combination with nme1-p6 (Fig. 2B) . In addition, a deletion of the gene for the pseudouridine synthase, Pus7, which is necessary for the proper pseudouridylation of U2 RNA (23), exhibits a genetic interaction with RNase MRP (Fig. 2B) . The detection of U2 RNA associated with Rmp1, the elevated U2 RNA levels in RNase MRP mutants, and the genetic interactions between RNase MRP components and U2 components strongly suggest a direct association between U2 RNA and RNase MRP.
CTS1 mRNA Is Elevated in RNase MRP Mutants-CTS1 encodes an endochitinase required for the degradation of the primary septum during cytokinesis. Northern blot analysis of CTS1 mRNA in nme1-⌬2, nme1-p6, snm1-172, and snm1-p18 strains as compared with their respective wild-type strains indicated that it is elevated in all RNase MRP mutants (Fig. 1B) . Interestingly, CTS1 mRNA levels in nme1-⌬2 are considerably higher than in the other three mutants. This could partially be due to the general catalytic activity of RNase MRP being more impaired or alternatively to a loss of substrate specificity for CTS1 mRNA in this mutant. CTS1 has previously been identified as having a long 5Ј-UTR (217-231 nucleotides) analogous to the CLB2 mRNA, the first identified mRNA substrate of RNase MRP (9, 24, 25).
To determine whether this region of the CTS1 mRNA can be processed by RNase MRP, we performed a cleavage assay whereby we subjected in vitro transcribed RNA containing the CTS1 5Ј-UTR to RNase MRP enzyme purified from yeast (Fig.  3A) . The CTS1 5Ј-UTR substrate was cleaved at a rate equivalent to that of the 5.8 S rRNA A3 substrate. Similar to the CLB2 substrate, multiple cleavage sites were seen (9). To establish the exact sites of RNase MRP cleavage on the CTS1 5Ј-UTR, we performed primer extension analysis to map the cleavage sites. As can be seen (Fig. 3B) , nine sites were identified throughout the transcript. These sites appear to be a collection of five major sites accompanied by some minor sites. The cleavage profile as indicated was invariable throughout several assays, indicating a degree of specificity in substrate cleavage (Fig. 3B) . The RNase MRP cleavage profile of CTS1 and CLB2 suggests that the enzyme works in a processive manner, establishing recognition and cleaving the substrate repeatedly (Fig. 3B and Ref. 9 ). This manner of cleavage is similar to what has been reported in mouse nuclear RNase MRP enzyme cleavage of mitochondrial substrate (26, 27) . A search for consensus sites in known substrates revealed no compelling recognition sequence. However, the first cleavage site does match the 2CUC consensus seen previously (Ref. 28 and supplemental Fig. 1) .
CTS1 Levels Do Not Return to Normal Levels after M Phase in an
RNase MRP Mutant-The hallmark of deregulation of a cell cycle-regulated transcript is a failure to return to normal levels after peak expression. To determine whether the levels of CTS1 are affected in an RNase MRP mutant, wild-type and mutant cells were synchronized with hydroxyurea and released, and RNA was collected at various time points after release. As is the case with CLB2 mRNA deregulation in an nme1-p6 mutant (9), CTS1 mRNA levels peak normally during mitosis but fail to cycle back down in an nme1-⌬2 mutant as compared with wild type (Fig. 4A) . CTS1 is temporally regulated to trigger the degradation of the primary septum following chromosomal segregation for cytokinesis to occur (29) . This temporal regulation may be affected in RNase MRP mutants due to extended transcript stability.
CTS1 mRNA Degradation Requires Both RNase MRP and Xrn1-Having established that CTS1 mRNA is a substrate for RNase MRP, we sought to determine whether CTS1 mRNA stability is Xrn1-dependent like the CLB2 mRNA (9). By comparing CTS1 mRNA levels in nme1-⌬2, ⌬xrn1, nme1-⌬2/ ⌬xrn1, and wild-type strains, we found that CTS1 mRNA stability is greater in the double mutant compared with either single mutant or the wild-type strain (Fig. 4B ). This suggests that CTS1 mRNA is targeted for degradation by the Xrn1 exoribonuclease following RNase MRP cleavage in its 5Ј-UTR. This result suggests that the degradation of the CTS1 mRNA occurs in TAM bodies by RNase MRP and Xrn1 in a manner identical to CLB2 mRNA (8).
Ty1 RNA Elements Associate with Rmp1 and Are Reduced in RNase MRP Mutants-Ty1 elements are yeast retrotransposons that make up a significant portion of the yeast genome and are typically dormant for transposition. Their replication is cell cycle-regulated, and unlike Ty3 elements, they transpose in a manner that is almost universally dependent on tRNA proximity (30) . Ty1 is among the most abundant RNAs found to associate with Rmp1. Unexpectedly, Northern analysis of Ty1 RNA from time fractions of synchronized cells indicated that Ty1 levels are reduced over 5-fold in the RNase MRP mutant nme1-⌬2 (Fig. 4A ). This result is more consistent with RNase MRP playing a role in Ty1 maturation instead of stability. Improper assembly of a mature particle would be expected to produce lower levels of the Ty1 RNA.
DISCUSSION
Through the use of RIP-chip, we have identified several novel RNase MRP substrates. These additional substrates further implicate the critical role RNase MRP plays in cell cycle regulation. The identified substrates of RNase MRP share several common characteristics including roles in cell cycle progression, specific subcellular localization, and tight gene regulation. The identification of RNase MRP-associated TAM bodies and these newly identified substrates suggest that RNase MRP serves a specific role in the regulation of key transcripts, which may be asymmetrically distributed within the cell, to ensure proper cell division and continued cell viability (8).
These results place RNase MRP as a key player in the regulation of the spatiotemporal regulation of cell division by regulating key transcripts involved in the spatial positioning and resolution of cytokinesis. RNase MRP has been found in TAM bodies, cytoplasmic bodies that localize to the daughter cell prior to cytokinesis (8). It is in these TAM bodies that it is believed RNase MRP cleaves the CLB2 transcript. Interestingly, the CTS1 gene is also under cell cycle control and is asymmetrically expressed in daughter cells (31, 32) . The synergistic effects of an RNase MRP/xrn1 double mutant indicate that like the CLB2 mRNA CTS1 is processed in its 5Ј-UTR by RNase MRP to remove the cap and then rapidly degraded by the Xrn1 5Ј to 3Ј exonuclease (8). Sic1 is a cyclin/cyclin-dependent kinase inhibitor with high levels correlating with an exit from the cell cycle and low levels coinciding with cell cycle progression and an increased risk of cancer development in mammals (20). It is unclear why RNase MRP would process the SIC1 mRNA if it is promoting cell cycle exit; however, degradation of this mRNA may help to fine-tune the next cell cycle in daughter cells along a temporal path different from that of the mother cell.
The finding that the U2 snRNA LSR1 is a substrate of RNase MRP is surprising and raises the possibility that RNase MRP might play a role in the biogenesis of ribonucleoproteins other than the ribosome. LSR1 may require a processing event by RNase MRP for full function and assembly. This is consistent with the synthetic sick phenotype seen between an RNase MRP RNA mutant and a deletion of either LEA1 or MSL1. Both of these encode non-essential components of the U2 spliceosome. In addition, PUS7 encodes a pseudouridine synthase that catalyzes the pseudouridylation of two positions in U2, and DBR1 encodes the RNA lariat debranching enzyme important for intron turnover. Both the Dbr1 and Pus7 proteins have alternative functions (33) , but the indication of U2 RNA as an RNase MRP substrate along with the MSL1 and LEA1 genetic interactions points to U2 as the root cause of the genetic interaction observed between these genes and the RNase MRP RNA NME1. We did not detect any accumulation of unspliced actin transcript in an RNase MRP mutant, but subtle transcript-specific splicing changes may still exist. Interestingly, the levels of CTS1, SIC1, and LSR1 mRNAs were differentially affected in nme1-⌬2 versus nme1-p6 mutants. This contrasts with the 5.8 S rRNA processing defects that are typically seen in both mutants, suggesting an allele-specific difference in substrate selection phenotypes. As the human homolog of NME1, RMRP, is mutated in cartilage-hair hypoplasia, these results may provide an understanding of the pleomorphic effects of RNase MRP mutants in humans (34) . In addition, cartilage-hair hypoplasia patients have been found to exhibit an increased incidence of certain forms of cancer, which may be linked to cell cycle defects triggered by the failure of RNase MRP to process key cell cycle-regulated genes (35) .
An unexpected result of this screen was the identification of a role for RNase MRP in Ty1 element transposition. This evidence is made even more interesting by the recent discovery that P-body elements are necessary for normal Ty1 transposition. P-bodies are cytoplasmic mRNA processing sites that like TAM bodies are sites of mRNA degradation. In addition, they share at least one common protein with TAM bodies (8, 36).
Loss of P-body processing negatively effects Ty1 replication and thus transposition in yeast (37) (38) (39) . Recently, RNase MRP has been found to play a role in viral RNA degradation of tomato bushy stunt virus when hosted in S. cerevisiae (40) . Whether or not MRP is necessary for proper assembly of the Ty1 particle as may be the case with U2 or in degradation of the Ty1 RNA remains to be determined. The decrease in the levels of Ty1 RNA implies that RNase MRP is required in a processing event to stabilize and prevent degradation of the RNA by potentially promoting its assembly with particular proteins.
These results clearly implicate RNase MRP as a key enzyme not only in the maintenance of ribosomal RNA processing but also in the continued regulation of mitotic events. RNase MRP appears poised to degrade key transcripts in a specific subcellular space to help fine-tune the cell cycle. Moreover, RNase MRP appears to have been co-opted to help in the processing and maturation of other ribonucleoprotein particles in the cell (41) . Additional research into this enzyme will undoubtedly reveal additional substrates and activities that will pro-FIGURE 3. A, cleavage of in vitro transcribed CTS1 5Ј-UTR RNA and 5.8 S rRNA A3 by purified RNase MRP. 3Ј-End-labeled RNA of the 5.8 S rRNA A3 site was used as a positive control for RNase MRP cleavage activity. Similarly labeled CTS1 5Ј-UTR RNA was generated, and both were subjected to increasing amounts of RNase MRP enzyme for 30 min. B, determination of RNase MRP cleavage sites on the CTS1 5Ј-UTR. Cleavage products generated from in vitro transcribed CTS1 5Ј-UTR by purified RNase MRP were subjected to primer extension with CTS1-R3 primer and separated on a sequencing gel next to the CTS1 5Ј-UTR DNA sequence using the same primer. Positions of cleavage sites (*1-*9) are indicated and are mapped in supplemental Fig. 1 . nt, nucleotides.
vide valuable insight into cell cycle regulation by RNase MRP and the development of the associated diseases in humans.
